A researcher at Vanderbilt has identified a set of 15 genes that together exhibit a 24-hour gene expression pattern in human blood, constituting a circadian clock biomarker.
Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response.
Accessibility Tools